WKB Lawyers has advised Selvita on its acquisition of PozLab. DSK Kancelaria reportedly advised the sellers.
Selvita specializes in integrated research and development projects in the area of drug discovery and development that combine the early stage of drug discovery with the clinical trial stage.
PozLab is an independent research and development laboratory that provides R&D analytical services to the pharmaceutical, food, cosmetics, veterinary, and related industries.
The WKB team included Partner Jakub Jedrzejak, Counsel Bartosz Laski, and Attorneys at Law Sebastian Wozniak, Zuzanna Cybulska, Dorota Gajuk, and Marta Palyga.
